Tuberculosis 2012: biology, pathogenesis and intervention strategies; an update from the city of light

Tuberculosis (TB) remains one of the world's most deadly infectious diseases, with approximately 1.5 million deaths and 9 million new cases of TB in 2010. There is an urgent global need to develop new control tools, with advances necessary in our basic understanding of the pathogen, Mycobacteri...

Full description

Saved in:
Bibliographic Details
Published in:Research in microbiology 2013-04, Vol.164 (3), p.270-280
Main Authors: Gouzy, Alexandre, Nigou, Jérôme, Gilleron, Martine, Neyrolles, Olivier, Tailleux, Ludovic, Gordon, Stephen V.
Format: Article
Language:English
Subjects:
Drug Resistance, Bacterial
Genetic Variation
Host-Pathogen Interactions
Human health and pathology
Immunology
Infectious diseases
Innate immunity
Life Sciences
Microbial Sensitivity Tests
Mycobacteria
Mycobacterium tuberculosis
Mycobacterium tuberculosis - genetics
Mycobacterium tuberculosis - immunology
Mycobacterium tuberculosis - pathogenicity
Mycobacterium tuberculosis - physiology
Tuberculosis
Tuberculosis - drug therapy
Tuberculosis - microbiology
Tuberculosis - pathology
Tuberculosis Vaccines
Tuberculosis Vaccines - immunology
Virulence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tuberculosis (TB) remains one of the world's most deadly infectious diseases, with approximately 1.5 million deaths and 9 million new cases of TB in 2010. There is an urgent global need to develop new control tools, with advances necessary in our basic understanding of the pathogen, Mycobacterium tuberculosis, and translation of these findings to public health. It was in this context that the “Tuberculosis 2012: Biology, Pathogenesis, Intervention Strategies” meeting was held in the Institut Pasteur, Paris, France from 11 to 15th Sept 2012. The meeting brought together over 600 delegates from across the globe to hear updates on the latest research findings and how they are underpinning the development of novel vaccines, diagnostics, and drugs.
ISSN:0923-2508
1769-7123
0923-2508
DOI:10.1016/j.resmic.2012.12.006